Mast cells and mastocytosis

Digestive Diseases

Volumn 27, Issue SUPPL. 1, 2010, Pages 129-136

  Söderholm, Johan D ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Inflammatory bowel disease; Irritable bowel syndrome; Stress; Systemic mastocytosis

Indexed keywords

ANTIHISTAMINIC AGENT; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CD2 ANTIGEN; CHEMOKINE RECEPTOR CXCR2; CHEMOTACTIC FACTOR; CLADRIBINE; CROMOGLYCATE DISODIUM; DNA; GAMMA INTERFERON; HISTONE; IMATINIB; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 1; INTERLEUKIN 13; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; NEUROPEPTIDE; PROSTAGLANDIN; PROTEOGLYCAN; RAPAMYCIN; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR; TOLL LIKE RECEPTOR; TRYPTASE; TUMOR NECROSIS FACTOR ALPHA; TYROSINE KINASE RECEPTOR; UNINDEXED DRUG;

ABDOMINAL PAIN; ANTIGEN EXPRESSION; BONE MARROW BIOPSY; CAPILLARY PERMEABILITY; CELL ACTIVATION; CELL DIFFERENTIATION; CELL GROWTH; CELL INFILTRATION; CONFERENCE PAPER; CROHN DISEASE; CYTOREDUCTIVE SURGERY; DIARRHEA; ELECTRON MICROSCOPY; ENDOSCOPY; ENTERITIS; ENTEROCOLITIS; ESOPHAGITIS; FIBROSIS; FOOD ALLERGY; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL HEMORRHAGE; HEPATOMEGALY; HUMAN; IRRITABLE COLON; MALABSORPTION; MAST CELL; MASTOCYTOSIS; NAUSEA AND VOMITING; PATHOPHYSIOLOGY; PEPTIC ULCER; PHAGOCYTOSIS; PORTAL HYPERTENSION; PRIORITY JOURNAL; SKIN DEFECT; SPLENOMEGALY; STEATORRHEA; TELANGIECTASIA;

ANIMALS; HUMANS; MAST CELLS; MASTOCYTOSIS; MASTOCYTOSIS, SYSTEMIC;

EID: 77950799129     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000268133     Document Type: Conference Paper

References (65)

1. Yu LC, Perdue MH: Role of mast cells in intestinal mucosal function: studies in models of hypersensitivity and stress. Immunol Rev 2001; 179: 61-73.
2. Santos J, Yang PC, Söderholm JD, Benjamin M, Perdue MH: Role of mast cells in chronic stress induced colonic epithelial barrier dysfunction in the rat. Gut 2001; 48: 630-636. (Pubitemid 32378581)
3. Wallon C, Yang PC, Keita AV, Ericson AC, McKay DM, Sherman PM, et al: Corticotropin-releasing hormone (CRH) regulates macromolecular permeability via mast cells in normal human colonic biopsies in vitro. Gut 2008; 57: 50-58.
4. Feger F, Varadaradjalou S, Gao Z, Abraham SN, Arock M: The role of mast cells in host defense and their subversion by bacterial pathogens. Trends Immunol 2002; 23: 151-158. (Pubitemid 34178298)
5. Kockritz-Blickwede M, Goldmann O, Thulin P, Heinemann K, Norrby-Teglund A, Rohde M, et al: Phagocytosis-independent antimicrobial activity of mast cells by means of extracellular trap formation. Blood 2008; 111: 3070-3080.
6. van der Kleij HP, Ma D, Redegeld FA, Kraneveld AD, Nijkamp FP, Bienenstock J: Functional expression of neurokinin 1 receptors on mast cells induced by IL-4 and stem cell factor. J Immunol 2003; 171: 2074-2079. (Pubitemid 36966491)
7. Tkaczyk C, Okayama Y, Metcalfe DD, Gilfillan AM: Fcgamma receptors on mast cells: activatory and inhibitory regulation of mediator release. Int Arch Allergy Immunol 2004; 133: 305-315. (Pubitemid 38529224)
8. Marshall JS: Mast-cell responses to pathogens. Nat Rev Immunol 2004; 4: 787-799.
9. el-Lati SG, Dahinden CA, Church MK: Complement peptides C3a-and C5a-induced mediator release from dissociated human skin mast cells. J Invest Dermatol 1994; 102: 803-806.
10. Christerson UA, Keita AV, Söderholm JD, Gustafson-Svard C: Increased expression of protease-activated receptor-2 in mucosal mast cells in Crohn's ileitis. J Crohns Colitis 2009; 3: 100-108.
11. Bischoff SC: Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data. Nat Rev Immunol 2007; 7: 93-104.
12. Bischoff SC: Physiological and pathophysiological functions of intestinal mast cells. Semin Immunopathol 2009; 31: 185-205.
13. Rao KN, Brown MA: Mast cells: multifaceted immune cells with diverse roles in health and disease. Ann NY Acad Sci 2008; 1143: 83-104.
14. Austen KF, Boyce JA: Mast cell lineage development and phenotypic regulation. Leuk Res 2001; 25: 511-518. (Pubitemid 32506757)
15. Lennartsson J, Jelacic T, Linnekin D, Shivakrupa R: Normal and oncogenic forms of the receptor tyrosine kinase kit. Stem Cells 2005; 23: 16-43. (Pubitemid 40105289)
16. Kitamura Y, Go S, Hatanaka K: Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. Blood 1978; 52: 447-452. (Pubitemid 8395558)
17. Morimoto M, Kasugai T, Tei H, Jippo-Kanemoto T, Kanakura Y, Kitamura Y: Agedependent amelioration of hypoplastic anemia in Ws/Ws rats with a small deletion at the kinase domain of c-kit. Blood 1993; 82: 3315-3320. (Pubitemid 23356701)
18. Metcalfe DD, Akin C: Mastocytosis: molecular mechanisms and clinical disease heterogeneity. Leuk Res 2001; 25: 577-582. (Pubitemid 32506765)
19. Valent P, Akin C, Sperr WR, Mayerhofer M, Fodinger M, Fritsche-Polanz R, et al: Mastocytosis: pathology, genetics, and current options for therapy. Leuk Lymphoma 2005; 46: 35-48.
20. Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB, et al: Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 2001; 25: 603-625. (Pubitemid 32506768)
21. Jensen RT: Gastrointestinal abnormalities and involvement in systemic mastocytosis. Hematol Oncol Clin North Am 2000; 14: 579-623.
22. Lee JK, Whittaker SJ, Enns RA, Zetler P: Gastrointestinal manifestations of systemic mastocytosis. World J Gastroenterol 2008; 14: 7005-7008.
23. Shah NP, Lee FY, Luo R, Jiang Y, Donker M, Akin C: Dasatinib (BMS-354825) inhibits KITD816V, an imatinib-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis. Blood 2006; 108: 286-291. (Pubitemid 43990640)
24. Patnaik MM, Rindos M, Kouides PA, Tefferi A, Pardanani A: Systemic mastocytosis: a concise clinical and laboratory review. Arch Pathol Lab Med 2007; 131: 784-791. (Pubitemid 46726143)
25. Patnaik MM, Tefferi A, Pardanani A: Kit: molecule of interest for the diagnosis and treatment of mastocytosis and other neoplastic disorders. Curr Cancer Drug Targets 2007; 7: 492-503. (Pubitemid 47196209)
26. Ogilvie-McDaniel C, Blaiss M, Osborn FD, Carpenter J: Mastocytic enterocolitis: a newly described mast cell entity. Ann Allergy Asthma Immunol 2008; 101: 645-646.
27. Jakate S, Demeo M, John R, Tobin M, Keshavarzian A: Mastocytic enterocolitis: increased mucosal mast cells in chronic intractable diarrhea. Arch Pathol Lab Med 2006; 130: 362-367.
28. Tu Y, Salim S, Bourgeois J, Di L, Di Leo V, Irvine EJ, Marshall JK, et al: CD23-mediated IgE transport across human intestinal epithelium: inhibition by blocking sites of translation or binding. Gastroenterology 2005; 129: 928-940. (Pubitemid 41242685)
29. Tu Y, Perdue MH: CD23-mediated transport of IgE/immune complexes across human intestinal epithelium: role of p38 MAPK. Am J Physiol Gastrointest Liver Physiol 2006; 291: G532-G538.
30. Lenz HJ, Raedler A, Greten H, Vale WW, Rivier JE: Stress-induced gastrointestinal secretory and motor responses in rats are mediated by endogenous corticotropin-releasing factor. Gastroenterology 1988; 95: 1510-1517.
31. Lenz HJ, Burlage M, Raedler A, Greten H: Central nervous system effects of corticotropin-releasing factor on gastrointestinal transit in the rat. Gastroenterology 1988; 94: 598-602.
32. Nakade Y, Fukuda H, Iwa M, Tsukamoto K, Yanagi H, Yamamura T, et al: Restraint stress stimulates colonic motility via central corticotropin-releasing factor and peripheral 5-HT3 receptors in conscious rats. Am J Physiol Gastrointest Liver Physiol 2007; 292: G1037-G1044.
33. Tache Y, Bonaz B: Corticotropin-releasing factor receptors and stress-related alterations of gut motor function. J Clin Invest 2007; 117: 33-40.
34. Theoharides TC, Kalogeromitros D: The critical role of mast cells in allergy and inflammation. Ann NY Acad Sci 2006; 1088: 78-99.
35. Wallon C, Söderholm JD: Corticotropin-releasing hormone and mast cells in the regulation of mucosal barrier function in the human colon. Ann NY Acad Sci 2009; 1165: 206-210.
36. Castagliuolo I, Lamont JT, Qiu B, Fleming SM, Bhaskar KR, Nikulasson ST, et al: Acute stress causes mucin release from rat colon: role of corticotropin releasing factor and mast cells. Am J Physiol 1996; 271:G884-G892.
37. Santos J, Saperas E, Nogueiras C, Mourelle M, Antolin M, Cadahia A, et al: Release of mast cell mediators into the jejunum by cold pain stress in humans. Gastroenterology 1998; 114: 640-648.
38. Santos J, Saunders PR, Hanssen NP, Yang PC, Yates D, Groot JA, et al: Corticotropinreleasing hormone mimics stress-induced colonic epithelial pathophysiology in the rat. Am J Physiol 1999; 277:G391-G399.
39. Demaude J, Salvador-Cartier C, Fioramonti J, Ferrier L, Bueno L: Phenotypic changes in colonocytes following acute stress or activation of mast cells in mice: implications for delayed epithelial barrier dysfunction. Gut 2006; 55: 655-661.
40. Kiliaan AJ, Saunders PR, Bijlsma PB, Berin MC, Taminiau JA, Groot JA, et al: Stress stimulates transepithelial macromolecular uptake in rat jejunum. Am J Physiol 1998; 275:G1037-G1044.
41. Theoharides TC, Letourneau R, Patra P, Hesse L, Pang X, Boucher W, et al: Stress-induced rat intestinal mast cell intragranular activation and inhibitory effect of sulfated proteoglycans. Dig Dis Sci 1999; 44(suppl 8): S87-S93.
42. Castagliuolo I, Wershil BK, Karalis K, Pasha A, Nikulasson ST, Pothoulakis C: Colonic mucin release in response to immobilization stress is mast cell dependent. Am J Physiol 1998; 274:G1094-G1100.
43. Söderholm JD, Yang PC, Ceponis P, Vohra A, Riddell R, Sherman PM, et al: Chronic stress induces mast cell-dependent bacterial adherence and initiates mucosal inflammation in rat intestine. Gastroenterology 2002; 123: 1099-1108.
44. Barreau F, Cartier C, Leveque M, Ferrier L, Moriez R, Laroute V, et al: Pathways involved in gut mucosal barrier dysfunction induced in adult rats by maternal deprivation: corticotrophin-releasing factor and nerve growth factor interplay. J Physiol 2007; 580: 347-356.
45. Barclay GR, Turnberg LA: Effect of psychological stress on salt and water transport in the human jejunum. Gastroenterology 1987; 93: 91-97.
46. Crowe SE, Perdue MH: Anti-immunoglobulin E-stimulated ion transport in human large and small intestine. Gastroenterology 1993; 105: 764-772.
47. Alonso C, Guilarte M, Vicario M, Ramos L, Ramadan Z, Antolin M, et al: Maladaptive intestinal epithelial responses to life stress may predispose healthy women to gut mucosal inflammation. Gastroenterology 2008; 135: 163-172.
48. Grotjohann I, Schmitz H, Fromm M, Schulzke JD: Effect of TNF alpha and IFN gamma on epithelial barrier function in rat rectum in vitro. Ann NY Acad Sci 2000; 915: 282-286.
49. Soderholm JD, Streutker C, Yang PC, Paterson C, Singh PK, McKay DM, et al: Transcellular permeability defect in the ileum of Crohn's disease mediated by tumour necrosis factor alpha. Gut 2004; 53: 1817-1824.
50. Cenac N, Coelho AM, Nguyen C, Compton S, Andrade-Gordon P, MacNaughton WK, et al: Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2. Am J Pathol 2002; 161: 1903-1915.
51. Jacob C, Yang PC, Darmoul D, Amadesi S, Saito T, Cottrell GS, et al: Mast cell tryptase controls paracellular permeability of the intestine. Role of protease-activated receptor 2 and beta-arrestins. J Biol Chem 2005; 280: 31936-31948.
52. Guilarte M, Santos J, de Torres I, Alonso C, Vicario M, Ramos L, et al: Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. Gut 2007; 56: 203-209.
53. Barbara G, Stanghellini V, De Giorgio R, Cremon C, Cottrell GS, Santini D, et al: Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004; 126: 693-702.
54. Piche T, Saint-Paul MC, Dainese R, Marine-Barjoan E, Iannelli A, Montoya ML, et al: Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome. Gut 2008; 57: 468-473.
55. Gecse K, Roka R, Ferrier L, Leveque M, Eutamene H, Cartier C, et al: Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity. Gut 2008; 57: 591-599.
56. Piche T, Barbara G, Aubert P, Bruley des Varannes S, Dainese R, Nano JL, et al: Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Gut 2009; 58: 196-201.
57. De Schepper HU, De Man JG, Moreels TG, Pelckmans PA, De Winter BY: Review article: gastrointestinal sensory and motor disturbances in inflammatory bowel disease-clinical relevance and pathophysiological mechanisms. Aliment Pharmacol Ther 2008; 27: 621-637.
58. King T, Biddle W, Bhatia P, Moore J, Miner PB Jr: Colonic mucosal mast cell distribution at line of demarcation of active ulcerative colitis. Dig Dis Sci 1992; 37: 490-495.
59. Gelbmann CM, Mestermann S, Gross V, Kollinger M, Scholmerich J, Falk W: Strictures in Crohn's disease are characterised by an accumulation of mast cells colocalised with laminin but not with fibronectin or vitronectin. Gut 1999; 45: 210-217.
60. Andoh A, Deguchi Y, Inatomi O, Yagi Y, Bamba S, Tsujikawa T, et al: Immunohistochemical study of chymase-positive mast cells in inflammatory bowel disease. Oncol Rep 2006; 16: 103-107.
61. Okumura S, Yuki K, Kobayashi R, Okamura S, Ohmori K, Saito H, et al: Hyperexpression of NOD2 in intestinal mast cells of Crohn's disease patients: preferential expression of inflammatory cell-recruiting molecules via NOD2 in mast cells. Clin Immunol 2009; 130: 175-185.
62. Farré R, De Vos R, Geboes K, Verbeke K, Vanden Berghe P, Depoortere I, et al: Critical role of stress in increased oesophageal mucosa permeability and dilated intercellular spaces. Gut 2007; 56: 1191-1197.
63. Feldman MJ, Morris GP, Dinda PK, Paterson WG: Mast cells mediate acid-induced augmentation of opossum esophageal blood flow via histamine and nitric oxide. Gastroenterology 1996; 110: 121-128.
64. Cao J, Papadopoulou N, Kempuraj D, Boucher WS, Sugimoto K, Cetrulo CL, et al: Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor. J Immunol 2005; 174: 7665-7675.
65. Wu SV, Yuan PQ, Wang L, Peng YL, Chen CY, Tache Y: Identification and characterization of multiple corticotropin-releasing factor type 2 receptor isoforms in the rat esophagus. Endocrinology 2007; 148: 1675-1687.